Clinical Trial Update: First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness [NA]

View source ↗

Summary

A first-in-human study evaluating the CorNeat KPro for corneal blindness was terminated; results have been posted as of 2024-09-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Blindness
• Corneal Injuries
• Corneal Opacity

Drugs mentioned

• CorNeat KPro

Snippet

Sponsor: CorNeat Vision Ltd. | Conditions: Corneal Disease, Corneal Opacity | NA | Status: TERMINATED | Results posted: 2024-09-24